In her editorial published by RXinsider, Katy F Lees, Virtue 340B’s Principal 340B Compliance Advisor, explores four developments covered entities should be watching:
• Proposed changes to Medicare outpatient reimbursement
• The revised 340B rebate model pilot
• Expansion of Medicare’s Maximum Fair Price program
• Proposed mandatory reporting to the Medicare Part D 340B claims repository
These developments carry different policy statuses and operational implications. Effective preparation means connecting them to your organization’s drugs, claims, purchasing, cash flow, and pharmacy workflows.
Katy’s central message aligns with our work at Virtue 340B: detailed program knowledge, dependable data, and clear accountability help covered entities assess exposure and prepare thoughtfully as policies evolve.
Read “Ready for 2027: What 340B Covered Entities Need to Know Now”



